250+ investors that invest in your industry and stage
Transportation
Gaming
Community
Proptech
FinTech
Biotech
Climate
Marketplace
Artificial intelligence
Energy
Hardware
Media (entertainment)
EdTech
Consumer
Health Care
Impact
Enterprise
Agriculture (agtech)
Sustainability
Venture Capital
Restaurants
Fashion
Real Estate
Retail
Infrastructure
Mobile Apps
Beauty
LGBT
Web3
Publishing
Clean Energy
Sporting Goods
Oil and Gas
B2B
Education
Organic Food
Big Data
Renewable Energy
Food and Beverage
Cryptocurrency
Finance
Video Games
Financial Services
Payments
Photography
Celebrity
Art
Medical
Digital Media
Music
Internet
Social Media
Manufacturing
Facebook
Franchise
Blockchain
Legal
Android
Social Impact
Mobile
Google
Construction
Sports
Local
eSports
Enterprise Software
Email
Wellness
Social Network
Hospitality
Travel
Fitness
Mobile Advertising
Cannabis
Recruiting
Platforms
Biotechnology
Medical Device
Wine And Spirits
Automotive
Crowdfunding
Social
CleanTech
InsurTech
SaaS
Software
Film
Theatre
Life Science
Non Profit
Qatar
New Zealand
United States
South Korea
Germany
Australia
India
United Kingdom
Ireland
Canada
Africa
Asia
LATAM
Europe
Oceania
Middle East
China
South Africa
Singapore
Brazil
Japan
Indonesia
Sri Lanka
Vietnam
Spain
Saudi Arabia
Argentina
Armenia
Austria
Bangladesh
Bahrain
Belarus
Bulgaria
Belgium
Bermuda
Chile
Cameroon
Switzerland
Colombia
Belize
Costa Rica
Denmark
Ecuador
Algeria
Czech Republic
Georgia
Estonia
Egypt
Ghana
Hong Kong
Ethiopia
Gibraltar
Faroe Islands
Greece
Finland
Croatia
France
Hungary
Barbados
Kuwait
Italy
Jersey
Israel
Lebanon
Cambodia
Kenya
Cayman Islands
Jordan
Lithuania
Liberia
Liechtenstein
Myanmar
Kazakhstan
Mali
Morocco
Norway
Malaysia
Mexico
Panama
Malta
Mauritius
Peru
Philippines
Nicaragua
Pakistan
Poland
Russian Federation
Romania
Sweden
Rwanda
Serbia
Seychelles
Turkey
Togo
Puerto Rico
Slovenia
Sierra Leone
San Marino
Senegal
Tunisia
Tanzania
Tajikistan
El Salvador
Uganda
Zambia
Uzbekistan
Thailand
Taiwan
Ukraine
Uruguay
Zimbabwe
Venezuela
Portugal
Azerbaijan
Bahamas
Guatemala
Iraq
Iceland
Namibia
Nigeria
United Arab Emirates
Honduras
Bolivia
Isle of Man
Luxembourg
Cyprus
Latvia
Oman
Angel investors
VC Funds
All investors
Download Find emails Save list

Top 50 Biotechnology Startup Investors in Oceania in October 2023

A list of 50 angel investors and VC (Venture Capital) funds that invest in Biotechnology startups based in Oceania. We rank investors based on the number of investments they made in Biotechnology companies from Oceania. We update this investor list every month.

Top 50 Biotechnology Startup Investors in Oceania in October 2023

Investor Biotechnology Oceania investments
Uniseed Ventures 21
Brandon Capital Partners 15
Medical Research Commercialisation Fund (MRCF) 11
Icehouse Ventures 7
Stoic VC 7
OneVentures 6
Enterprise Angels 5
Melbourne Angels 5
New Zealand Venture Investment Fund 5
Artesian VC 5
Main Sequence Ventures 4
K1W1 4
Clean Energy Finance Corporation 3
Matū Fund 3
Starfish Ventures 3
Yuuwa Capital 3
Finistere Ventures 3
Horizons Ventures 3
Brisbane Angels 2
Possible Ventures 2
Allan Moss 2
Sydney Angels 2
BridgeLane Capital 2
South Australian Venture Capital Fund 2
IP Group 2
Folklore Ventures 2
Global Health Investment Fund (GHIF) 2
Rabobank Food & Agri Innovation Fund 2
Grok Ventures 2
Vectr 2
Lowercarbon Capital 2
Custos Privatstiftung 1
Negev Capital 1
Understorey Ventures 1
Australian Nuclear Science and Technology Organization 1
Serge van Dam 1
Sante Ventures 1
UniSA Ventures 1
NOAB Ventures 1
David Ross 1
BioScience Managers Limited 1
Melanie Melanie 1
Powerhouse Ventures 1
Powerhouse Ventures 1
Marko Bogoievski 1
Movac 1
RIV Capital 1
Ellerston Capital 1
Dexcom Ventures 1
Regal Funds Management 1

Get 300+ niche investors in 2 minutes.

Find who invests in your industry, stage, and region in our 200k+ database with AI-powered matching.

Find investors — It's Free!

Trusted by 21,000+ founders from:

Y Combinator Techstars Antler Pioneer On Deck
Investor list
Uniseed Ventures
VC Fund · Brisbane, Queensland, Australia · 3 investments in the past 12 months

Uniseed was established in October 2000 as a $20 million joint venture between the University of Melbourne (UM) and the University of Queensland (UQ). This proof of concept fund (Fund-1) operated with significant input and support from the commercialization offices of the two universities (UniQuest and Melbourne Ventures Limited), with staff ofthese organizations making up the majority of the Investment Committee and leading due diligence and management of most investment opportunities. Over 20 investments, typically of $250,000 - $500,000 were made from this fund.A new $40 million venture fund (Fund-2) ran from 2005-15, with the addition of a third leading university, the University of New South Wales, and a major private institutional investor, the Westscheme superannuation fund. The founding universities (UQ & UM) also committed further funds. Australian Super took over Westscheme's essets and commitments in July 2011.With the start of Fund-2, an independent management team was established, consisting of the CEO and three Investment Managers; one at each university catchment. The Investment Committee was restructured, with dedicated committees established for biotechnology or other technologies. The nominal investment limit was increased to $2.5 million to allow participation in follow-on funding rounds so as to preserve Uniseed's equity position.On 1 November 2015, Uniseed started its third and largest fund (Fund-3) with the addition of the University of Sydney and the CSIRO to the Universities of Queensland, Melbourne and NSW. This followed three high profile exits in the preceding 14 months (Fibrotech; Spinifex & Hatchtech). Each of the five partners committed $10 million over 10 years to the new fund (total fund $50 million).Uniseed’s partner research organisations spent nearly $4 billion on research, making up over 40% of the total research spend at 67 research organisations in Australia. Together, these organisations accounted for nearly 500 invention disclosures (34% of total) and 500 new registered IP rights filed (45% of total) over the same period(2013 National Survey of Research Commercialisation). Unlike private venture capital funds, Uniseed is dedicated to the needs of its research partners, and committed to servicing them consistently over the long term, irrespective of the short term conditions in external capital markets. It works in very close partnership with the research partner commercialisation companies and staff, providing a valuable adjunct to the capabilities these companies and staff provide. They in turn provide a best-practice commercialisation service tailored to their respective organisations. These companies are able to leverage to great effect the scale of operation and expertise of the Uniseed network.The fund is run with commercial discipline, ensuring independence and financial rigor in its investment decision-making processes. Success is measured by a balance of return on investment (including the flow of funds for research to further the commercialisation of intellectual property generated within the research partner catchments), the establishment of viable start-up companies, the generation of research income for research partners and the improvement of partner commercialisation processes.

Show more...

Investment focus

  • Biotechnology, Manufacturing, Health Care
  • Series A, Seed, Funding Round
  • Australia, United States, United Kingdom

Portfolio highlights

  • Ferronova — Ferronova is a medical device company that offers imaging and surgery products.
  • Morse Micro — Smarter, farther, better. Meet the latest Wi-Fi, HaLow, 802.11ah. 10X FARTHER>1Km range, 100x area, 1000x volume 10X EFFICIENCYMulti-year on a single
  • Tiny Bright Things — Melbourne-based company Tiny Bright Things was cofounded in 2020 by long-time research collaborators Ray Dagastine and Chris Bolton. We invented Halo microscopy to transform the way researchers and manufacturers look at small or transparent things. This helps manufacturers in areas like agrichemicals and pharmaceuticals (where the size and shape ofpowders are critical) and researchers at every stage of discovery— particularly in nanotechnology (where samples are especially tiny) and life sciences (where samples are often also transparent).
Show more investments...

Brandon Capital Partners
VC Fund · Melbourne, Victoria, Australia · 3 investments in the past 12 months

Brandon Capital invests in the most promising biomedical opportunities that have the potential to improve the lives of patients.

Show more...

Investment focus

  • Biotechnology, Health Care, Medical
  • Series A, Seed, Series B
  • Australia, United States, United Kingdom

Portfolio highlights

  • CatalYm — Catalym develops antibodies against a placental factor which is overexpressed by various tumour types.
  • Entact Bio — Entact Bio is a biotechnology company that is in the preclinical stages of developing medications to improve protein function. It was founded by a team with deep roots in deubiquitinase (DUB) biochemistry, chemical biology, disease biology, and small-molecule drug development. The company's proprietary EncompassTM platform was designed tocreate enhancement-targeting chimeric (ENTACTM) medicines. ENTACs take advantage of DUBs' ability to regulate proteins.
  • NRG Therapeutics — energizing drug discovery in neurodegenerative diseases.
Show more investments...

Medical Research Commercialisation Fund (MRCF)
VC Fund · Melbourne, Victoria, Australia

Medical Research Commercialisation Fund (MRCF) provides dedicated, investment funding to support the commercialisation of early-stage medical research discoveries that originate from its member institutes. The collaborative nature of the MRCF seeks to foster best practice in the commercialisation of medical innovations.

Show more...

Investment focus

  • Biotechnology, Health Care, Medical
  • Series A, Seed, Series B
  • Australia, United States, United Kingdom

Portfolio highlights

  • Glyscend — Glyscend develops a revolutionary approach to treating type 2 diabetes. The company began with the insight that bariatric surgery can lead to the immediate remission of the disease, and has since been engaged in the development of a non-invasive approach which will act on the same mechanism as surgery but fit within the current care pathway. Thecompany's technology is an orally ingestible intestinal coating that prevents the stimulation of duodenal mucosa and inhibits key neurohormonal pathways in the proximal gut. Glyscend is devoted to providing patients with an effective strategy to keep glucose levels under control and eliminate potential side effects like weight gain and hypoglycemia. Meanwhile, the company aims to provide endocrinologists and primary care physicians with the innovative tools they need to treat the disease instead of merely managing it. It was founded in 2014 by co-founders Ashish Nimgaonkar, Michael Parlato, and Pratik Patel.
  • Currus Biologics — Currus Biologics is a biotechnology company that develop CAR-T cell therapies for the treatment of solid tumour cancers.
  • Azura Ophthalmics — Azura Ophthalmics is a clinical-stage company that develops an innovative portfolio of compounds to advance treatments for MGD, the leading cause of DED. By targeting the root cause of MGD, Azura brings the promise of improved health and well-being to millions of people worldwide who suffer from MGD and other ocular surface diseases where treatmentoptions are currently lacking. Azura is underpinned by an experienced management team with an established track record of successfully developing and commercializing novel treatments for ocular surface diseases. The company headquartered in Tel Aviv-Yafo, Israel with operations in Australia and the U.S.
Show more investments...

Icehouse Ventures
VC Fund · Auckland, Auckland, New Zealand · 14 investments in the past 12 months

Icehouse Ventures is an early-stage venture capital firm. We exist to back the world's bravest Kiwi founders, launching global companies from New Zealand.

Show more...

Investment focus

  • Software, SaaS, Information Technology
  • Seed, Series A, Funding Round
  • New Zealand, United States, Australia

Portfolio highlights

  • DataMasque — Simply mask your sensitive data while maintaining its function for testing, development, training and analytics. DataMasque makes it safe to explore, implement and harness the opportunities that data provides, free from privacy concerns or compromise.
  • Aquila — We're powering the future by building and operating an infinitely scalable energy network.
  • Scentian Bio — Scentian Bio operates as a platform that provides ultimate sensing solution.
Show more investments...

Stoic VC
VC Fund · Sydney, New South Wales, Australia · 1 investment in the past 12 months

Stoic VC is an early-stage venture fund backing founders at the forefront of University Innovation. We partner with Uniseed to accelerate the commercialisation of university research across the ANZ.

Show more...

Investment focus

  • Biotechnology, Medical, Health Care
  • Seed, Funding Round, Series A
  • Australia, United States, United Kingdom

Portfolio highlights

  • Ena Respiratory — Ena Respiratory is a biotechnology company seeking to transform the treatment and prevention of respiratory infections and the effectiveness of vaccines.Ena Respiratory novel, synthetic Toll-like receptor 2 (TLR2) receptor agonists have been shown to activate the innate immune system in the respiratory tract and prevent viral and bacterialdissemination to the lungs.
  • BioScout — Welcome to BioScout, your partner in revolutionizing the agriculture industry with cutting-edge automated disease detection technology for crop growers and viticulture. Our high-level introduction and detailed insights into our innovative solutions, exceptional collaborations, and dedicated team make it easy to understand WHO we are, WHAT we do, and HOW we do it. Stay updated with valuable resources, customer portal, and regular content via our blog. Contact us today to collaborate and optimize your farm's productivity and sustainability.
  • Lenexa Medical — Lenexa Medical is driving towards better healthcare solutions for patients in hospital and aged-care by preventing pressure injuries and empowering clinicans.
Show more investments...

OneVentures
VC Fund · Sydney, New South Wales, Australia · 4 investments in the past 12 months

OneVentures is one of Australia’s leading venture capital firms, with over $330M in funds under management. But they do more than invest. They take companies to that all important next stage, by actively shaping their future. They apply their years of international experience, operational and executional expertise to accelerate the growth of theirportfolio companies. A global growth focus drives their investment selection with their current portfolio including companies with truly innovative products tackling multi-billion-dollar problems, from needle-free vaccinations to virtual communications to adaptive e-learning.

Show more...

Investment focus

  • Software, Health Care, Information Technology
  • Series A, Debt Financing, Funding Round
  • Australia, United States, Israel

Portfolio highlights

  • Vaxxas — Vaxxas develops and commercializes needle-free vaccine delivery system. Vaxxas was incorporated in 2011 and is based in Brisbane, Australia.
  • BiVACOR — BiVACOR is a privately held company founded in 2008. Their staff includes world-class engineers, medical specialists, and business executives, who are diligently working to advance this ground-breaking technology. Together, they have established a strong collaborative network that extends both nationally and internationally. Their worldheadquarters is located in Houston, Texas, USA, and their international office is in Brisbane, Australia.
  • ImmVirX — ImmVirX is an Australian company founded in 2019 with a mission to improve outcomes for patients with cancer types in which immunotherapy treatments have limited effect.
Show more investments...

Enterprise Angels
VC Fund · Tauranga, Gisborne, New Zealand

Connecting startup business owners with angel investors to raise capital . Access a network of expertise and investment opportunities.

Show more...

Investment focus

  • Software, Information Technology, Health Care
  • Funding Round, Seed, Angel
  • New Zealand, United States, United Kingdom

Portfolio highlights

  • Cropsy Technologies — Cropsy's mission is to deliver disruptive, scalable technology to every fruit grower to unlock the full potential of their land with insights that were impossible before. Our proprietary AI-enabled hardware allows growers to monitor every plant, understand the whole crop, and track how it changes over time. These insights help growers optimiseall their decision making. The system is a simple tractor add-on, so growers do all their daily operations while Cropsy looks out for problems. Cropsy is poised to set the new gold standard for growing, with recommendations, forecasts, and providing certainty to every grower, every season.
  • Cetogenix — Cetogenix is a clean technology business dedicated to creating long-term solutions to global climate change.
  • Zenno Astronautics — At Zenno Astronautics, our hardware and software products ensure satellite missions are effectively managed, guaranteeing maximum economic returns and responsible use of space.
Show more investments...

Melbourne Angels
VC Fund · Melbourne, Victoria, Australia

Melbourne Angels was formed in Melbourne, Australia in early 2007. Melbourne Angels is the leading group of private investors in Victoria who actively invest in early stage and growth technology companies.The group has a strong and experienced core of members that generate deal flow, are experienced in evaluation of business propositions and actas mentors for the other members and the entrepreneurs. The members vary in age, gender, ethnicity, profession and type of experience. All members have experience of success at being entrepreneurial.This award winning group is consistently one of the most active startup investors in the country.

Show more...

Investment focus

  • Biotechnology, Information Technology, Manufacturing
  • Angel, Seed, Funding Round
  • Australia, United States, New Zealand

Portfolio highlights

  • Tayble — Spend more time enjoying your food and less time waiting.We hate waiting...For anything...And food and drinks are no exception!If your hobbies include:- Waiting in line - Calling out to a waiter - Watching the kettle boil - Calculating your split of the billPLEASE DO NOT DOWNLOAD THIS APP... YOU'LL HATE IT!But if you're likeus...And want your food and drinks ready exactly when you are...Or to leave a restaurant without worrying about your bill...Then step right up, this bad boy's for you!With Tayble, you’ll never have to flag down a waiter... EVER!Simply order from your "Tayble"Or before you even arrive...Leave the rest to us and the 1,000's of minions in the cloud that keep this all running!You’ll be left asking where has this been all my life, guaranteed!*(Definitely not a real guarantee)
  • Insite AI — We create predictability for consumer brands in the unpredictable world of retail. Game-changing technology that attacks consumer brands' hardest problems.
  • Apop Imaging — Apop Imaging develops and commercialises novel imaging, diagnostic and therapeutic tools to improve patient outcomes based on our proprietary calcitonin receptor antibody technology.
Show more investments...

New Zealand Venture Investment Fund
VC Fund · Auckland, Auckland, New Zealand

Your guide to finding and using government services.

Show more...

Investment focus

  • Software, Biotechnology, SaaS
  • Seed, Series A, Angel
  • New Zealand, United States, Japan

Portfolio highlights

  • Insite AI — We create predictability for consumer brands in the unpredictable world of retail. Game-changing technology that attacks consumer brands' hardest problems.
  • Invert Robotics — Invert Robotics develops robotic NDT inspection technologies for the maintenance of industrial equipment in the food and beverage, pharmaceutical, and oil and gas industries. Invert Robotics highly skilled team of engineers have developed a world leading modular inspection platform suitable for use across a range of industries and applications.
  • Surgical Design Studios — The Insides Company is the leading provider of chyme reinfusion solutions for intestinal failure
Show more investments...

Artesian VC
VC Fund · Melbourne, Victoria, Australia · 13 investments in the past 12 months

Artesian Capital Management is an alternative investments management company, which was spun out of ANZ Banking Group's capital markets business in 2004, with backing from ANZ Private Equity. Artesian's founding partners, purchased ANZ's stake in 2005. The company has subsequently been fully owned by partners and staff. Since 2004,Artesian has managed specialised funds focused on credit arbitrage and relative-value strategies across global financial markets. In 2008, while continuing to manage credit relative value investment strategies from its New York, London and Singapore offices, Artesian began to make principal investments in seed/early-stage ventures from its offices in Sydney, Melbourne and Shanghai. In 2011, Artesian launched the first of its early stage venture capital funds and now manages AUD +255m. Artesian's VC strategy is to partner with best of breed accelerators, incubators, angel groups and university programs. In 2017, Artesian launched its China VC Fund with a USD 50m cornerstone investment industry super fund Hostplus. Artesian will soon launch a Southeast Asia VC Fund.

Show more...

Investment focus

  • Software, Artificial Intelligence, Information Technology
  • Seed, Series A, Pre-Seed
  • Australia, United States, Hong Kong

Portfolio highlights

  • ZoomAgri — ZOOMAGRI provides an assessment of agricultural commodities to all participants of Agri supply chain via AI, computer vision and IoT.
  • Supplynote — End-to-end supply chain management tool to track inventory, orders, payments and suppliers online
  • Navi Medical Technologies — Navi Medical Technologies is a medical device development company.
Show more investments...

Main Sequence Ventures
VC Fund · Sydney, New South Wales, Australia · 15 investments in the past 12 months

We work with inventors who are building something hard from their unique expertise in science. These inventors are building the industries that will thrive for the decades to come. We have a unique working model to accelerate a company's pathway to scale.

Show more...

Investment focus

  • Software, Artificial Intelligence, Information Technology
  • Series A, Seed, Series B
  • Australia, United States, Philippines

Portfolio highlights

  • Endua — Endua is building the next generation of clean energy deep storage to power communities, remote industries and off-grid infrastructure at the flick of a switch - all day and night
  • Jdoodle — JDoodle is an Online Compiler, Editor, IDE for Java, C, C++, PHP, Perl, Python, Ruby and many more. You can run your programs on the fly online, and you can save and share them with others. Quick and Easy way to compile and run programs online.
  • Number 8 bio — Number 8 bio objective is to decarbonize agriculture while feeding the world's rising population. This can be accomplished by harnessing the power of trillions of carbon-hungry bacteria that feed on harmful greenhouse gases and turn them into profitable animal feeds.
Show more investments...

K1W1
VC Fund · Auckland, Auckland, New Zealand · 6 investments in the past 12 months

K1W1 provides startups and businesses in New Zealand with early and later-stage venture investments.

Show more...

Investment focus

  • Software, Biotechnology, SaaS
  • Seed, Series A, Funding Round
  • New Zealand, United States

Portfolio highlights

  • Daisy Lab — Daisy Lab pioneers precision fermentation technology in New Zealand
  • Aquafortus — Aquafortus specializes in providing enviornmental services and commercializes proprietary zero liquid discharge technology.
  • Mint Innovation — Founded in 2016, members of the Mint Innovation team have a strong background in chemistry, biotechnology, and leveraging IP in the industrial sector. They are scaling their technology in their Auckland plant and labs to demonstrate the commercial application of their biometallurgy processes for metal recovery.
Show more investments...

Clean Energy Finance Corporation
VC Fund · Sydney, New South Wales, Australia · 9 investments in the past 12 months

The Clean Energy Finance Corporation invests, applying commercial rigour, to increase the flow of finance into the clean energy sector. Their mission is to accelerate Australia's transformation towards a more competitive economy in a carbon constrained world, by acting as a catalyst to increase investment in emissions reduction. They do thisthrough an investment strategy focused on cleaner power solutions, including large and small-scale solar, wind and bioenergy; and a better built environment, with investments to drive more energy efficient property, vehicles, infrastructure and industry. The CEFC also invests with co-financiers to develop new sources of capital for the clean energy sector, including climate bonds, equity funds, aggregation facilities and other financial solutions. The CEFC operates under the Clean Energy Finance Corporation Act 2012.

Show more...

Investment focus

  • Energy, Solar, Renewable Energy
  • Series B, Series A, Seed
  • Australia, United States

Portfolio highlights

  • Infradebt — Infradebt t is a specialist fund manager providing clients with direct access to infrastructure private debt markets.
  • Gunn Agri Partners — Gunn Agri Partners is an agricultural investment company that offers advice and services for acquisitions, asset, farm, and fund management.
  • HydGene Renewables — Our mission is to accelerate adoption of low carbon technology by providing an alternative green hydrogen solution.
Show more investments...

Matū Fund
VC Fund · Auckland, Auckland, New Zealand

Investing in scalable science and deep tech start-ups in Aotearoa NZ. We operate venture capital funds that invest in science and deep tech through a hands-on, active approach.

Show more...

Investment focus

  • Biotechnology, Robotics, Nanotechnology
  • Seed
  • New Zealand, United States

Portfolio highlights

  • Ligar — Novel technology to rapidly and cost effectively capture and recover specific molecules or groups of molecules from liquids, such as bioactives, bitter flavours or contaminants from natural extracts, wine, water, juices, coffee and wastewater. [et_pb_column type="1_3"
  • Alimetry — Alimetry is a health technology startup based in Auckland, New Zealand, developing breakthrough solutions for diagnosing disorders of gastrointestinal (GI) function.
  • PowerON — Dielectric Elastomers for Soft Robotics
Show more investments...

Starfish Ventures
VC Fund · Melbourne, Victoria, Australia

Starfish Ventures is an Australian venture capital firm focused on information technology, life sciences, and clean technology companies.

Show more...

Investment focus

  • Software, Enterprise Software, Information Technology
  • Series A, Series B, Funding Round
  • United States, Australia, Philippines

Portfolio highlights

  • Aktana — Build stronger relationships with HCPs using Aktana's artificial intelligence (AI) platform for life sciences to optimize omnichannel engagement.
  • DesignCrowd — Crowdsourced logo, freelance graphic and web design at DesignCrowd. 1,136,169 freelance designers compete to create amazing designs for your business. Start Today!
  • Marani — Marani Health is developing a prenatal care platform which includes a wearable, textile-based product to measure key vital statistics of women and their developing fetus, for use during pregnancy, labor & delivery. The products utilize Artificial Intelligence to better assess health & wellness during pregnancy, labor & delivery. Maraniis collaborating with key partners including The Mayo Clinic.
Show more investments...

Yuuwa Capital
VC Fund · Perth, Western Australia, Australia

Yuuwa Capital is a $40M early-stage venture capital firm based in Perth, Western Australia. They are actively seeking outstanding investment opportunities where Yuuwa can provide both capital and expertise to help founders, management and early investors to turn good ideas into great companies.

Show more...

Investment focus

  • Biotechnology, Analytics, Health Care
  • Series A, Seed, Series B
  • Australia

Portfolio highlights

  • Nexgen Plants Pty Limited — Healthy plants, healthy people, living planet. Nexgen develop's plants for future generations that will improve the environment and health of future generations.
  • icetana — icetana Motion Intelligence dramatically improves the active monitoring of security surveillance networks, with AI video anomaly detection and video analytics.
  • Agworld Pty Ltd — Agworld Farm Management software allows you to collect data at all levels and enables you to extract maximum value from this data; optimising profitability. The Agworld ecosystem is utilised by growers, agronomists and service providers on farms across the world.
Show more investments...

Finistere Ventures
VC Fund · San Diego, California, United States · 2 investments in the past 12 months

Finistere Ventures is an agricultural technology and life sciences venture capital investor. Founded in 2005, the company partners with other entrepreneurs and creative thinkers to build innovative companies that have the potential to transform modern agriculture, increase food security, improve nutrition, and enhance sustainability. Their appliedexperience as operators, and pioneering role in Ag Tech, is actively utilized to benefit its portfolio companies and Partners. Finistere has global access to the best new technologies from centers of Ag Tech excellence in the U.S., Australia, Israel, New Zealand, and Canada through its venture partner networks. Finistere’s locations in San Diego and Palo Alto, California keeps them connected to the centers of mainstream venture investment and the world’s leading innovation ecosystem.

Show more...

Investment focus

  • Agriculture, Biotechnology, Farming
  • Series B, Series C, Series A
  • United States, Israel, New Zealand

Portfolio highlights

  • Scentian Bio — Scentian Bio operates as a platform that provides ultimate sensing solution.
  • Animol Discovery — Animol is building its own pipeline of break-through proprietary veterinary small molecules led by a team of animal health industry experts with vast experience in bringing drugs to market. With our unique and powerful technology platform we deliver innovative medicines that are specifically designed for the needs of veterinary patients.
  • Growers Edge — Growers Edge leverages data science to build grower-relevant risk management solutions to meet ever-changing agricultural demands.
Show more investments...

Horizons Ventures
VC Fund · Hong Kong, Hong Kong Island, Hong Kong · 17 investments in the past 12 months

Investing in the deep science and technology that can propel humanity towards a radically better future.

Show more...

Investment focus

  • Biotechnology, Artificial Intelligence, Software
  • Series A, Series B, Seed
  • United States, United Kingdom, Canada

Portfolio highlights

  • BioLoomics — BioLoomics is a preclinical stage biotechnology company that uses evolution in a microscope to develop drug discovery tools and protein drugs. Our VariVolve platform tests millions of protein designs for a targeted activity in hours, enabling efficient mining of the vast chemical space of protein designs. A strong advantage of our approach is theuse of whole intact cells as test vessels that capture complex drug behavior not attainable in conventional assays.
  • Erthos — erthos is a producer of biodegradable packaging materials intended to replace traditional polystyrene and polypropylene inputs.
  • ZeroAvia — ZeroAvia is producing the world's first practical zero emission aviation powertrain, initially targeting 20-seat airplanes to start replacing dirty jet fuel in regional transport
Show more investments...

Brisbane Angels
VC Fund · Brisbane, Queensland, Australia · 1 investment in the past 12 months

Formed in late 2006, the Brisbane Angels Pty Ltd is a large group of private investors who actively invest in early stage technology companies, usually in South East Queensland, Australia. The members are typically active or semi-retired former senior business executives, who apart from financial input can provide much needed value adding toinvestee companies through hands-on management experience and high level business networks.

Show more...

Investment focus

  • Software, Information Technology, Artificial Intelligence
  • Seed, Angel, Funding Round
  • Australia, United States, New Zealand

Portfolio highlights

  • Tribu — Here at tribu we aim to make running an MSP stress-free and simple. Remove complexity and repetitive shackles to give you the freedom in business so that you can have freedom in life.
  • Avasa — Avasa is a medical device company. It helps to improve surgical procedures by developing novel implantable devices.
  • One Key Access — One Key Access is an interface to the world of couriers to enable 24/7 frictionless deliveries.
Show more investments...

Possible Ventures
VC Fund · Munich, Bayern, Germany · 26 investments in the past 12 months

Possible Ventures backs ambitious teams building frontier technology to positively impact society. We invest globally in the early stages, actively supporting founders via our collective of global entrepreneurs.

Show more...

Investment focus

  • Software, Information Technology, Biotechnology
  • Seed, Pre-Seed, Series A
  • Germany, Australia, United States

Portfolio highlights

  • Automata — Automata is a deep-tech company that creates products that empower people to automate physical work. The company's product, Eva, is a lightweight and affordable robot arm built for professionals in a production line, in a lab, a home workshop or even in a classroom. People don't need to be technical experts to communicate with robots. Theweb-based software platform can be programmed by anyone, anywhere, any time, from any device, making it easy to reconfigure for a wide range of different tasks.Automata was founded on 2015 and is headquartered in London, England.
  • Eden Brew — Eden Brew is a ground-breaking new way to enjoy dairy products sustainably and nutritiously.
  • Pow.bio — Pow.bio provides fermentation services for synthetic biology.
Show more investments...

Allan Moss
Angel · Sydney, New South Wales, Australia

Allan Moss acts an adviser to Anchorage’s Investment Committee. Currently Principal of Allan Moss Investments, a private investment company, Allan retired from the role of Managing Director and Chief Executive Officer of Macquarie Group in May 2008. He was with Macquarie Group for 31 years and served as CEO from 1993 to his retirement in2008. He was also a non- executive director of CSR Ltd from 1996 to 2001.Allan graduated from Sydney University in Arts with a major in Economics and in Laws with Honours. He is also a graduate of Harvard University with a Masters Degree in Business Administration with High Distinction. Allan has received numerous industry awards and recognitions. He was twice named by Barron’s Magazine as one of the 30 most respected CEOs in the world (2006, 2007). He was appointed an Officer of the Order of Australia in 2005.

Show more...

Investment focus

  • Health Care, Medical Device, Biotechnology
  • Funding Round, Series A, Seed
  • Australia, United States, The Netherlands

Portfolio highlights

  • Skykraft — Skykraft is an Australian space services firm that specializes in smallsat constellation design, production, and operation.
  • Ferronova — Ferronova is a medical device company that offers imaging and surgery products.
  • Invert Robotics — Invert Robotics develops robotic NDT inspection technologies for the maintenance of industrial equipment in the food and beverage, pharmaceutical, and oil and gas industries. Invert Robotics highly skilled team of engineers have developed a world leading modular inspection platform suitable for use across a range of industries and applications.
Show more investments...

Sydney Angels
VC Fund · Sydney, New South Wales, Australia

Sydney Angels is a not-for-profit angel investment membership organisation. Since our establishment in 2008, they have stayed true to our mission of supporting the early-stage ecosystem by running processes and events that connect our investing members with promising early-stage companiesThey believe that encouraging smart investment in startupcompanies will benefit both our members’ portfolios and Australia’s emergent innovation economy.They see this as the ultimate win-win situation. Sydney Angels is led by an elected committee of ten volunteers who meet weekly. It is supported by an operations manager and alliance partners.

Show more...

Investment focus

  • Software, SaaS, Apps
  • Seed, Funding Round, Angel
  • Australia, United States

Portfolio highlights

  • Kapiche — Instant insights. No set up or coding. The Kapiche feedback analytics platform helps you ingest and analyze mountains of customer feedback in minutes.
  • Remi AI — A.I-Powered Demand Forecasting, Supply Chain AI, & Price Optimisation | Remi AI
  • Trendspek — Trendspek is the drone data solution asset managers use to make empowered decisions and ensure absolute asset knowledge. Conduct complete visual inspections from any web browser. Extract detailed insights without a site visit. Use powerful tools to analyse the structure and build a complete picture of asset condition. Enhance predictive maintenanceby closely monitoring trends. View different models side by side to observe important differences. Refine your understanding of an ever-changing asset.
Show more investments...

BridgeLane Capital
VC Fund · Sydney, New South Wales, Australia

The BridgeLane Group is a privately-owned asset management firm specialising in the agricultural, real estate and innovation sectors. A significant global player in agriculture with a multi-decade record in large scale farming, the Group has a proud history in residential property development, comme

Show more...

Investment focus

  • Software, Financial Services, Health Care
  • Seed, Series B, Funding Round
  • Australia, Germany

Portfolio highlights

  • Agerris — Agerris is a field robotics and AI start-up for the agriculture industry, based on technology created at the Australian Centre for Field Robotics, the University of Sydney, where they have been developing air and ground robotic solutions for the agriculture industry since 2005.
  • Sprout Stack
  • Evrima Technologies — Our clinical trial recruitment and management services put participants first. Trusted, timely clinical trial results are a good thing - for everybody.
Show more investments...

South Australian Venture Capital Fund
VC Fund · Adelaide, South Australia, Australia · 1 investment in the past 12 months

South Australian Venture Capital Fund - helping build dynamic and innovative South Australian startups / scaleups and accelerate their growth to a national and global scale.

Show more...

Investment focus

  • Health Care, Biotechnology, SaaS
  • Funding Round, Series A, Series B
  • Australia

Portfolio highlights

  • Lumary — Simplify Your Care Management Optimise Your Organisation Create Better Wellbeing
  • BiomeBank — BiomeBank is a clinical stage biotechnology company with a mission to treat our microbiome and prevent disease by restoring gut microbial ecology.
  • Ferronova — Ferronova is a medical device company that offers imaging and surgery products.
Show more investments...

IP Group
VC Fund · London, England, United Kingdom · 9 investments in the past 12 months

IP Group's core business is the creation of value for its shareholders and partners through the commercialisation of intellectual property originating from research intensive institutions. Their strength lies in managing this process from finding suitable intellectual property to commercialise to either helping develop businesses and createvalue out of them, or identifying and establishing appropriate commercial partnerships to do so. IP Group's extensive expertise in this area combined with its inside knowledge of both industry and finance have enabled the group to create a formidable track record of consistently delivering excellent results for their companies, for their partners and for their shareholders.

Show more...

Investment focus

  • Health Care, Biotechnology, Therapeutics
  • Seed, Series A, Series B
  • United Kingdom, United States, Australia

Portfolio highlights

  • AccelerComm — Our patented, market-leading IP solutions for 4G and 5G are configurable for quick, high-performance implementations across a wide range of applications.
  • Deep Render — Deep Render Ltd. is a spin-out from the Department of Computing at Imperial College London. We are a London based AI start-up that is developing the next generation of media compression algorithms. Our proprietary and patented technology is at the forefront of machine learning research. Furthermore, our Biological Image Compression results arestate-of-the-art, providing at least a 50% efficiency gain over the previous standards
  • Crescendo Biologics — Crescendo Biologics is a new Cambridge-based company whose vision is to deliver next-generation antibody therapeutics based on novel class-leading platforms.The focus of the company is on developing platforms that will address key issues in generating high-affinity, soluble, human VH antibody fragments. These are the smallest fragments thatretain antibody binding, and have many desirable properties as potential therapeutics. Crescendo will then utilise these platforms for product development of in-house targets or in partnership with other companies.
Show more investments...

Folklore Ventures
VC Fund · Sydney, New South Wales, Australia · 1 investment in the past 12 months

Folklore is a team of investors, founders, and builders committed to supporting Australian and New Zealand tech founders. We are a first cheque to forever investment firm, and we believe in the power of founder vision and the potential of teams, right from the start.

Show more...

Investment focus

  • Software, Apps, Information Technology
  • Seed, Series A, Funding Round
  • Australia, New Zealand, United States

Portfolio highlights

  • Swoop Aero — Transforming how the world moves by making access to the skies seamless.
  • HealthMatch — HealthMatch is a medical technology company that applies machine learning and artificial intelligence to clinical data to save lives.We aim to dramatically accelerate patient recruitment to clinical trials, and progress life-saving cures onto the market faster than existing practices allow.For clinicians and patients, there is a real struggleto identify and find appropriate trials, particularly where the criteria relating to each trial is inconsistently articulated. HealthMatch encodes qualifying questions relating to each patients condition. The platform matches responses to its trial dataset, and confirms only the correct-match trials for that patient — thereby streamlining the identification of suitable trials and facilitating a patient’s application to those trials.With Ai and software at the core, HealthMatch delivers a radically simple product to match patients with drug trials, backed by an execution approach to data that is deceptively complex to achieve and replicate. In doing so, HealthMatch is dramatically changing an industry that has essentially not moved beyond telephones and excel spreadsheets.
  • SimConverse — SimConverse is a simulation platform that uses generative AI to play the role of any patient, colleague or casualty.
Show more investments...

Global Health Investment Fund (GHIF)
VC Fund · New York, New York, United States

The Global Health Investment Fund (GHIF) is a $108 million social impact investment fund designed to provide financing to advance the development of drugs, vaccines, diagnostics and other interventions against diseases that disproportionately burden low- and middle-income countries. GHIF supports late-stage innovations for public health challengessuch as malaria, pre-eclampsia, cholera, HIV and river blindness, with an emphasis on infectious diseases and maternal/infant health issues that cause significant morbidity and mortality in resource-limited settings. GHIF may also make investments that improve or expand access to existing products—such as developing pediatric formulations of approved therapeutics or improving the stability of widely-used global health vaccines.As an investment fund with a limited time-horizon, GHIF seeks opportunities that have a high probability of successful commercialization within two or three years. Products with “dual market” potential are of greatest interest; i.e., those that will have a clear impact on public health in developing countries but also have value in high-income countries. High-volume / low-margin products, such as essential vaccines, are also of significant interest.GHIF employs a range of investment structures including mezzanine debt, convertible debt, preferred equity and project financing with an average investment target of approximately $10 million per project. Each GHIF project must advance the Fund’s social impact objectives and demonstrate the ability to achieve commercial success.

Show more...

Investment focus

  • Health Care, Biotechnology, Medical Device
  • Series B, Series C, Funding Round
  • United States, India, Austria

Portfolio highlights

  • Monod Bio — Monod Bio l Simple. Powerful. Biosensors for Medicine & Biotech.
  • CXL Ophthalmics — CXLO is developing a minimally invasive treatment for an ectatic corneal disease that can bring early intervention to millions of patients globally.
  • Endpoint Health — Endpoint Health is a precision-first therapeutics company. By rewriting the molecule-first drug development model, we aim to deliver precision therapies that have the potential to improve outcomes for patients with immune-driven illnesses.
Show more investments...

Rabobank Food & Agri Innovation Fund
VC Fund · Utrecht, Utrecht, The Netherlands · 1 investment in the past 12 months

Rabobank emerged from several small agricultural cooperative banks, founded by Dutch farmers in the late nineteenth century. Food & Agriculture (F&A) is in our DNA, from which we built a unique position in the F&A sector as a key financier and international player, attributes which we leverage for the benefit of our stakeholders andportfolio companies. We recognise and understand the food security challenges lying ahead of us and how Innovation in F&A supply chains is key to the solution, which is why we are dedicated to committing capital to the space.

Show more...

Investment focus

  • Agriculture, AgTech, Farming
  • Series A, Series B, Seed
  • United States, The Netherlands, Canada

Portfolio highlights

  • 30MHz — The data platform for horticulture | Sense. Act. Impact.
  • BeeHero — BeeHero - Your precision pollination provider for almonds, berries, apples and more We raise and keep exceptional bees by combining generations of commercial beekeeping experience with cutting-edge technology. Get premium bees & pollinate your crops with precision.
  • EarthOptics — EarthOptics is building the cloud-based machine learning platform for soil and ground management.
Show more investments...

Grok Ventures
VC Fund · Surry Hills, New South Wales, Australia · 6 investments in the past 12 months

Grok Ventures is a private investment company. They back world-class teams solving big problems to shape a better future. They invest in fast growing technology-enabled businesses.

Show more...

Investment focus

  • Renewable Energy, Software, Internet of Things
  • Series A, Series B, Seed
  • Australia, United States, Hong Kong

Portfolio highlights

  • Lydian — Lydian aims to accelerate the decarbonization of the chemical industry by electrifying the chemical production process. Founded in 2021 by Branko Zugic, Lydian is headquartered in
  • Loam Bio — Loam Bio is developing tech that allows for crops to be inoculated with symbiotic micro-organisms.
  • Fleet Space Technologies — Fleet is an agile, next generation connectivity company. Our mission is to Connect Everything using cutting-edge communications and space technologies to maximise the resource efficiency of human civilisation and enable the next industrial revolution with our free, ubiquitous connectivity platform.
Show more investments...

Vectr
VC Fund · Sheung Wan, Hong Kong Island, Hong Kong · 6 investments in the past 12 months

Vectr is a venture firm based in Hong Kong. They combine investment, creation and growth to deliver game-changing impact to teams ready to tackle global issues, transform industries and improve the lives of millions.That combines capital, creation and partnership to deliver game-changing impact. We strive to be the ideal partner for founders thatare building transformation products and looking to expand their businesses into asia.

Show more...

Investment focus

  • FinTech, Artificial Intelligence, Financial Services
  • Seed, Series A, Pre-Seed
  • United States, Hong Kong, Singapore

Portfolio highlights

  • Percent — Unlock private credit investments with Percent. Access alternative investments on the platform powering the future of private markets.
  • Micro Connect — Micro Connect provides market infrastructure, fintech, and platform development.
  • MasterExchange — Trading platform for music rights leveraging emerging technology to create friction free and compliant investment opportunities to everyone.
Show more investments...

Lowercarbon Capital
VC Fund · New York, New York, United States · 32 investments in the past 12 months

Lowercarbon Capital backs kickass companies slashing CO2 emissions, sucking carbon out of the sky, and buying us time to unf**k the planet.

Show more...

Investment focus

  • Biotechnology, Renewable Energy, Energy
  • Seed, Series A, Funding Round
  • United States, United Kingdom, France

Portfolio highlights

  • Dioxycle — Dioxycle is develop electrolyser solutions for carbon dioxide emissions.
  • Isometric — Isometric is a carbon removal registry and science platform
  • Arc Boats — Arc manufactures and sells high-performance electric boats for watersports.
Show more investments...

Custos Privatstiftung
VC Fund · 1 investment in the past 12 months

Custos Privatstiftung is a private company.

Show more...

Investment focus

  • Software, Biopharma, Nutrition
  • Series B, Seed, Series C
  • Israel, Austria, New Zealand

Portfolio highlights

  • Innovopro — Bringing a unique chickpea protein platform to the global food & beverage market, for creating nutritious, tasty, and sustainable food products.
  • Helico — Helico is developing a proprietary computational platform for synthetic biology research using modelling tools and AI-based prediction algorithms. The long-term aim is to develop a seed bank of different drugs able to be licensed to grow medical supplies in confined greenhouses anywhere in the world.
  • Authentic Vision — Protect your brand with anti counterfeiting technology from Authentic Vision, a leading provider of mobile authentication app solutions.
Show more investments...

Negev Capital
VC Fund · Grand Cayman, Midland, Cayman Islands · 1 investment in the past 12 months

Psychedelic Medical Intervention Investment Fund

Show more...

Investment focus

  • Biotechnology, Medical, Health Care
  • Seed, Series A, Series B
  • United States, Canada, Australia

Portfolio highlights

  • Psylo — Psylo is an Australia-based psychedelic biotech business focusing on Psychedelic-inspired medicine to treat mental illness.
  • Mindstate Design Labs — A psychedelic drug development company designing altered states of consciousness for mental health therapeutics.
  • Delix Therapeutics — Rewiring the brain to heal the mind
Show more investments...

Understorey Ventures
VC Fund · Sydney, New South Wales, Australia · 2 investments in the past 12 months

Understorey Ventures invests in critical solutions needed to restore planetary health.

Show more...

Investment focus

  • Software, Data and Analytics, Information Technology
  • Series A
  • United States

Portfolio highlights

  • FLINTpro — FLINTpro develops natural capital and carbon reporting software that supports organizations throughout their sustainability journey. It simplifies the processing of large and complex data sets, applies the latest scientific and analytical models and runs advanced simulations.
  • HydGene Renewables — Our mission is to accelerate adoption of low carbon technology by providing an alternative green hydrogen solution.
Show more investments...

Australian Nuclear Science and Technology Organization
VC Fund · Clayton, Victoria, Australia

Australian Nuclear Science and Technology Organisation is one of Australia's most important research infrastructures. Thousands of scientists in industry and academia gain access to state-of-the-art instruments every year. ANSTO operates much of Australia's landmark infrastructure, including OPAL, one of the world's most advancednuclear reactors; the Australian Synchrotron; the National Imaging Facility Research Cyclotron; and the Centre for Accelerator Science.

Show more...

Investment focus

  • Health Care, Biotechnology, Pharmaceutical
  • Funding Round
  • Australia

Portfolio highlights

  • Clarity Pharmaceuticals — Clarity is a clinical stage company developing products to address the growing need for the use of radiopharmaceuticals in oncology.
Show more investments...

Serge van Dam
Angel · Wellington, Wellington, New Zealand · 1 investment in the past 12 months

Serge has a depth of experience in technology startups that is difficult to rival. As CMO of M-Com, Serge led the growth of M-Com from a four person mobile commerce development company to the world's most successful provider of mobile banking and payment solutions (in both licensed and SaaS categories). He has since held executive levelpositions and Directorships, including as Chair on four boards, of many successful B2B SaaS companies. He is also an avid investor.

Show more...

Investment focus

  • Biotechnology, Product Research
  • Seed
  • New Zealand

Portfolio highlights

  • Daisy Lab — Daisy Lab pioneers precision fermentation technology in New Zealand
Show more investments...

Sante Ventures
VC Fund · Austin, Texas, United States · 5 investments in the past 12 months

Santé Ventures is a life sciences venture capital firm that invests exclusively in early-stage companies developing innovative new medical technologies or healthcare delivery models. The firm was founded in 2006 and has $281 million in capital under management in two funds.

Show more...

Investment focus

  • Health Care, Biotechnology, Medical
  • Series A, Series B, Series C
  • United States, Canada, New Zealand

Portfolio highlights

  • Wave Life — Saas, Mobile App, Service
  • ABK Biomedical — At ABK biomedical, we are focused on developing novel Y90 radioembolization treatment options for patients with hypervascular liver tumors
  • Surgical Safety Technologies — Surgical Safety Technologies delivers data-driven AI technology to hospitals for safe surgeries. It empowers surgeons with an objective assessment of technical and non-technical proficiency using academically validated frameworks.
Show more investments...

UniSA Ventures
VC Fund

UniSA Ventures is the technology commercialisation and investment management company of the University of South Australia (UniSA).

Show more...

Investment focus

  • Software, Health Care, Biotechnology
  • Seed
  • Australia

Portfolio highlights

  • Ferronova — Ferronova is a medical device company that offers imaging and surgery products.
  • Framework — All-in-one productivity tool for teams & individuals.
Show more investments...

NOAB Ventures
VC Fund · 2 investments in the past 12 months

NOAB Ventures operates as a venture capital firm.

Show more...

Investment focus

  • Solar, Energy, Energy Storage
  • Pre-Seed, Funding Round
  • Australia, New Zealand

Portfolio highlights

  • Relectrify — Unlocking extra lifetime and performance of batteries via advanced battery management (BMS) technology.
  • Vertus Energy — We innovate to make fossil natural gas extinct.
  • HydGene Renewables — Our mission is to accelerate adoption of low carbon technology by providing an alternative green hydrogen solution.
Show more investments...

David Ross
Angel

David Ross

Show more...

Investment focus

  • Biopharma, Biotechnology
  • Seed
  • New Zealand

Portfolio highlights

  • Helico — Helico is developing a proprietary computational platform for synthetic biology research using modelling tools and AI-based prediction algorithms. The long-term aim is to develop a seed bank of different drugs able to be licensed to grow medical supplies in confined greenhouses anywhere in the world.
Show more investments...

BioScience Managers Limited
VC Fund · Melbourne, Victoria, Australia

BioScience Managers Pty Ltd (formerly IB Managers) is a leading life sciences investment firm, headquartered in Melbourne, Australia. Established in 2003, BioScience Managers offers a global, multi-disciplinary team, bringing an international perspective together with the track record, networks and expertise required to convert that perspectiveinto informed, high return investment decisions.We operate a high value-add model, providing assistance and support to portfolio companies via our global team and international network of independent industry advisors. With combined experience of over 170 investments, more than 40 IPO’s/ reversals in Europe, the USA and Australia, and a diverse skillset specific to the bio-based industries, we aim to provide investee companies with significant value-add over and above capital invested.Alongside our funds management business, Phillip Bioscience Advisory provides specialist corporate advisory services to healthcare and life sciences companies.

Show more...

Investment focus

  • Health Care, Pet, Medical
  • Funding Round
  • Canada, Australia

Portfolio highlights

  • Nexvet — Our mission is to be a revolutionary force in the growing US$25 billion global animal pharmaceutical market. Only Nexvet can produce therapeutic antibodies that are 100% customised to target new species – like cats and dogs.Monoclonal antibody therapies have represented a new generation of highly effective, safe and targeted medicines inhumans. We think it’s time companion animals reaped the benefits of human medical progress in this field.Nexvet’s unique technology, PETisation™, ensures 100% customisation of a therapy to a new species, reducing the chances of immune challenges, and ensuring a more ‘natural’ fit between the therapy and the patient. Many chronic conditions in pets remain poorly treated by current veterinary therapies, such as pain and various inflammatory diseases– which has guided Nexvet’s focus towards these indications.To ensure we succeed in transforming animal medicine, we’ve brought together a team with an extraordinary global track record in animal and human health. We are working with leading contractors, advisors, drug development partners, academic groups, veterinarians and animal interest groups around the world to develop our pipeline to the highest standards.Senior executives and researchers from the world’s largest animal health brands are counted among our Board, management, and advisors, and together we’re building connections worldwide to make our vision a reality.
  • Canary Medical — Canary is giving medical devices a voice and letting medical data be heard.
  • Millenium Biologix — Millenium Biologix Corporation operates as a biomedical company primarily in the United States and Europe. It engages in the development and commercialization of implantable medical devices and skeletal tissue regeneration products for various orthopedic uses. The company offers Skelite, a synthetic bone graft, for healing and replacement.Millenium Biologix also develops Primacoll and Peptos for the stimulation of bone tissue growth. In addition, it offers ACTES, a cell culture and tissue engineering system, which provides automated control over the biological process of tissue engineering. The company was founded in 1986 and is headquartered in Kingston, Canada.
Show more investments...

Melanie Melanie
Angel · Wellington, Wellington, New Zealand · 1 investment in the past 12 months

Investor

Show more...

Investment focus

  • Biotechnology, Product Research
  • Seed
  • New Zealand

Portfolio highlights

  • Daisy Lab — Daisy Lab pioneers precision fermentation technology in New Zealand
Show more investments...

Powerhouse Ventures
VC Fund · Oakland, California, United States · 4 investments in the past 12 months

Powerhouse Ventures backs entrepreneurs building the digital infrastructure for rapid decarbonization.

Show more...

Investment focus

  • Software, Energy, Solar
  • Seed, Series A, Pre-Seed
  • United States, Australia, United Kingdom

Portfolio highlights

  • Tyba — Tyba provides end-to-end modeling of standalone and hybrid storage projects from early-stage development through operations, giving your business the edge to build and operate the best projects faster and more profitably.
  • Axiom Cloud — Axiom Cloud Inc. uses AI to solve the biggest energy and maintenance problems plaguing the underserved commercial cooling/refrigeration industry ($120B/year in the US alone). Our first target customer segment is retail grocery. Customers pay an initial setup fee to install/configure the IoT platform onsite, along with recurring SaaSfees for one or more cloud-based software apps that run on the IoT platform.
  • Granular Energy — Granular Energy provides solutions for managing and trading clean energy. Our tools have been developed to support the recent emergence of 24/7 time-stamped energy certificates as well as traditional "annual" certificates.
Show more investments...

Powerhouse Ventures
VC Fund · Christchurch, Canterbury, New Zealand

powerHouse is a New Zealand intellectual property commercialisation company investing to develop new spin-out ventures

Show more...

Investment focus

  • Solar, FinTech, Big Data
  • Seed, Series A, Funding Round
  • United States, New Zealand, The Netherlands

Portfolio highlights

  • Granular — Granular is a start-up providing market solutions for 24/7 clean energy.
  • Salient Predictions — Salient Predictions uses ML & ocean data to provide long range weather forecast for use in diverse industries.
  • Energetic Insurance — Let us cover the payment default risk on your next Solar Project. Energetic Insurance makes efficient financing possible for financiers, investors and energy service providers with the EneRate Credit Cover solar insurance policy.
Show more investments...

Marko Bogoievski
Angel

Marko retired as CEO of Morrison & Co in 2021 after 13 years of leading the business. He continues to provide guidance for investments in telecommunications and digital infrastructure. His 30 year career has been in the infrastructure and technology sectors in a variety of senior finance, operational and sales roles in the United States and NewZealand. Prior to joining Morrison & Co in 2008, Marko was CFO of Telecom NZ, responsible for corporate finance, M&A and group strategy. Marko is Chair of Vodafone New Zealand.

Show more...

Investment focus

  • Biotechnology, Manufacturing
  • Funding Round
  • New Zealand

Portfolio highlights

  • Pictor — Pictor is a biotechnology company develops, manufactures and market immunodiagnostic products.
Show more investments...

Movac
VC Fund · Wellington, Wellington, New Zealand · 3 investments in the past 12 months

Movac is New Zealand's most experienced technology investor and is deeply integrated into the Kiwi tech sector. We've been actively investing since 1998.

Show more...

Investment focus

  • Software, E-Commerce, SaaS
  • Seed, Series A, Funding Round
  • New Zealand, United States, Australia

Portfolio highlights

  • Atomic — Atomic embeds native, actionable customer interaction inside your iOS, Android or web app. Turn your customer data and insights into loyalty, retention and conversion.
  • ZeroJet — ZeroJet is the first jet propulsion system to be designed specifically for an electric motor, delivering the perfect balance of performance and runtime.
  • Mint Innovation — Founded in 2016, members of the Mint Innovation team have a strong background in chemistry, biotechnology, and leveraging IP in the industrial sector. They are scaling their technology in their Auckland plant and labs to demonstrate the commercial application of their biometallurgy processes for metal recovery.
Show more investments...

RIV Capital
VC Fund · Toronto, Ontario, Canada

RIV Capital building a leading cannabis CPG platform focused on discovering, acquiring, and accelerating brands that align with our premium vision.

Show more...

Investment focus

  • Cannabis, AgTech, Health Care
  • Seed, Funding Round, Series A
  • Canada, United States, Italy

Portfolio highlights

  • Dynaleo — At Dynaleo, we produce the highest quality cannabis-infused Edible Gummies. Learn more about our innovative CBD and THC gummies on our website.
  • Headset — Retail & market insights for cannabis retailers, product manufacturers, CPGs, processors, growers & all ancillary services.
  • TerrAscend — A Leading Vertically-Integrated North American OperatorTerrAscend is a leading North American cannabis operator with vertically integrated operations in
Show more investments...

Ellerston Capital
VC Fund · Sydney, New South Wales, Australia · 1 investment in the past 12 months

Ellerston Capital is a specialist investment manager with a distinctive approach to portfolio construction and investment selection.

Show more...

Investment focus

  • Software, Information Technology, E-Commerce
  • Funding Round, Seed, Series A
  • Australia, Hong Kong, United Kingdom

Portfolio highlights

  • Willed — Willed is an Australian online estate planning platform.
  • BiomeBank — BiomeBank is a clinical stage biotechnology company with a mission to treat our microbiome and prevent disease by restoring gut microbial ecology.
  • Internet 2.0 — Military Grade cyber security with core products Cloaking Firewall, Malcore and 5th Column
Show more investments...

Dexcom Ventures
VC Fund · San Diego, California, United States

The inaugural fund will seek to identify and invest in opportunities to supplement growth in the core business and advance the development of adjacent technologies for the future.

Show more...

Investment focus

  • Sensor, Medical, Wearables
  • Funding Round
  • Australia

Portfolio highlights

  • Nutromics — Nutromics is a MedTech company revolutionising healthcare through continuous real time molecular monitoring. Our Smart Patch biosensor platform will solve some of the biggest healthcare challenges we face today in the fields of chronic disease prevention, chronic disease management, acute diseases and Therapeutic Drug Monitoring.
Show more investments...

Regal Funds Management
VC Fund · Sydney, New South Wales, Australia · 3 investments in the past 12 months

Regal Funds Management was founded in 2004 by Andrew and Philip King. Regal utilises a long/short investment strategy and performs investment management and investment advisory services to a number of Australian Unit Trusts and Cayman Island Companies.

Show more...

Investment focus

  • Software, Financial Services, FinTech
  • Funding Round, Series B, Convertible Note
  • Australia, United States, United Kingdom

Portfolio highlights

  • Nykaa — Nykaa is an e-Commerce platform for different beauty and wellness products for men and women. They also offer comprehensive content including product reviews, beauty how-to videos, articles by experts, and an e-beauty magazine. Their helpline helps to choose products and services best suited for customer's needs. Nykaa's products areauthentic sourced directly from brands and provide a delivery experience.Nykaa was founded in 2012 by Falguni Nayar and is headquartered in Mumbai, Maharashtra, India.
  • SendFX — SendFX provides cross-border payment and remittance services to individuals and SMEs.
  • Send Payments — Send is a fast-growing fintech delivering embedded finance solutions to well-known brands.
Show more investments...
Investors by industry
Investors by country
Investors in Oceania by industry

Close your round

Find who invests in your industry, stage, and region in our 200k+ database with AI-powered matching.

Find investors — It's Free!

Join 21,000+ founders from:

Y Combinator Techstars Antler Pioneer On Deck